Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Blood and Blood Components Market: By Product, By Collection Method, By End-user, and Geography
Blood and Blood Components Market size was valued at US$ 13,732.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2030. Blood and blood components are essential for various medical treatments, including surgeries, trauma care, and haematological disorders. The market encompasses whole blood, red blood cells, platelets, plasma, and other blood-derived products. These components play crucial roles in transfusion medicine, with applications ranging from treating anaemia to supporting patients undergoing chemotherapy. The market's growth is driven by factors such as the increasing prevalence of chronic diseases, rising surgical procedures, and advancements in blood collection and processing technologies.
According to the World Health Organization, approximately 118.5 million blood donations are collected globally each year, yet there remains a significant gap between supply and demand, particularly in developing countries. The COVID-19 pandemic has further highlighted the importance of a robust blood supply chain, with many regions experiencing shortages due to reduced donations and increased demand for convalescent plasma. This has spurred innovations in blood collection, storage, and distribution methods. However, the market faces challenges such as the risk of transfusion-transmitted infections, stringent regulatory requirements, and the high cost of blood screening and processing. These factors can limit access to safe blood products, especially in resource-constrained settings
Study Period
2024-2030Base Year
2023CAGR
2.9%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The blood and blood components market is influenced by a complex interplay of medical, technological, and socioeconomic factors. The growing prevalence of blood disorders, such as leukaemia and thalassemia, drives demand for transfusion products. The American Cancer Society estimated 60,530 new leukaemia cases in the U.S. in 2020, many requiring blood transfusions as part of their treatment. Simultaneously, the ageing global population contributes to increased demand, as older individuals are more likely to require blood transfusions for various medical procedures. Technological advancements are reshaping the market landscape, with innovations like pathogen reduction technologies enhancing blood product safety. The plasma-derived products segment, a key component of the market, is experiencing rapid growth due to rising applications in treating immune deficiencies and neurological disorders. However, the market faces significant challenges, including the persistent risk of transfusion reactions and the development of alternatives like synthetic blood substitutes. Ethical considerations surrounding blood donation and the need for culturally sensitive approaches to encourage donation in diverse populations also impact market dynamics. Additionally, the global disparities in access to safe blood products highlight the need for improved infrastructure and blood management systems, particularly in low- and middle-income countries.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 13,732.9 million |
Market CAGR |
2.9% |
By Product |
|
By Collection Method |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global blood and blood components market size was valued at US$ 13,732.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.9% from 2023 to 2030.
The global blood and blood components market is segmented based on product, collection method, end-user, and geography.
The leading players in the market include Becton, Dickinson and Company, Terumo Corporation, Grifols S.A., CSL Limited, and Haemonetics Corporation, among others.
North America dominated the Blood and blood components market due to advanced healthcare systems, high healthcare expenditure, and the presence of major industry players.
The market is primarily driven by factors such as the increasing prevalence of chronic diseases, the rising number of surgical procedures, technological advancements in blood collection and processing methods, and growing awareness about blood donation.
1.Executive Summary |
2.Global Blood and Blood Components Market Introduction |
2.1.Global Blood and Blood Components Market - Taxonomy |
2.2.Global Blood and Blood Components Market - Definitions |
2.2.1.Product |
2.2.2.Collection Method |
2.2.3.End User |
2.2.4.Region |
3.Global Blood and Blood Components Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Blood and Blood Components Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Blood and Blood Components Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Whole Blood |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Red Blood Cells |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Platelets |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Plasma |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6.Global Blood and Blood Components Market By Collection Method, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Manual Method |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Apheresis |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Blood and Blood Components Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Surgical Centers |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Blood Banks |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Blood and Blood Components Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Whole Blood |
9.1.2.Red Blood Cells |
9.1.3.Platelets |
9.1.4.Plasma |
9.1.5.Others |
9.2. Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Manual Method |
9.2.2.Apheresis |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Ambulatory Surgical Centers |
9.3.3.Blood Banks |
9.3.4.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Whole Blood |
10.1.2.Red Blood Cells |
10.1.3.Platelets |
10.1.4.Plasma |
10.1.5.Others |
10.2. Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Manual Method |
10.2.2.Apheresis |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Ambulatory Surgical Centers |
10.3.3.Blood Banks |
10.3.4.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Whole Blood |
11.1.2.Red Blood Cells |
11.1.3.Platelets |
11.1.4.Plasma |
11.1.5.Others |
11.2. Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Manual Method |
11.2.2.Apheresis |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Ambulatory Surgical Centers |
11.3.3.Blood Banks |
11.3.4.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Whole Blood |
12.1.2.Red Blood Cells |
12.1.3.Platelets |
12.1.4.Plasma |
12.1.5.Others |
12.2. Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Manual Method |
12.2.2.Apheresis |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Ambulatory Surgical Centers |
12.3.3.Blood Banks |
12.3.4.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Whole Blood |
13.1.2.Red Blood Cells |
13.1.3.Platelets |
13.1.4.Plasma |
13.1.5.Others |
13.2. Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Manual Method |
13.2.2.Apheresis |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Ambulatory Surgical Centers |
13.3.3.Blood Banks |
13.3.4.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Becton, Dickinson and Company |
14.2.2.Terumo Corporation |
14.2.3.Grifols S.A. |
14.2.4.CSL Limited |
14.2.5.Haemonetics Corporation |
14.2.6.Fresenius Kabi AG |
14.2.7.Biomat S.A. |
14.2.8.Octapharma AG |
14.2.9.LFB Group |
14.2.10.Kedrion S.p.A. |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players